Cytokine and chemokine modification by Toll‐like receptor polymorphisms is associated with nasopharyngeal carcinoma
Authors:
Open Access
- 9 February 2012
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 103 (4) , 653-658
Abstract
Toll‐like receptors (TLR) play a pivotal role in sensing a wide range of pathogens, including bacteria, fungi and viruses. A dysregulation of TLR signaling may increase the risk of developing chronic inflammatory diseases and cancers. The aim of this study was to investigate the association of TLR2 R753Q, TLR4 D299G, and T399I polymorphisms with nasopharyngeal carcinoma (NPC) and to explore the effects of these polymorphisms on cytokine and chemokine expression in NPC biopsies. The genotypes of the three loci among 236 patients with NPC and 287 healthy controls were determined by PCR‐RFLP. Cytokines and chemokines mRNA and protein in NPC biopsies were measured by real‐time quantitative PCR and ELISA, respectively. Results showed that the combined CT/TT genotype of T399I was associated with increased NPC risk, with an odds ratio of 1.853 (95% confidence interval: 1.184–2.961). Also, individuals with the T allele of T399I showed a 1.842‐fold increase in NPC risk compared to those with the T399I C allele (95% confidence interval: 1.213–3.015). Messenger RNA levels of interleukin (IL)‐1α, tumor necrosis factor‐α and IL‐10 were significantly elevated in patients with T399I combined CT/TT genotype; IL‐1α and IL‐10 protein concentration significantly increased in NPC patients with T399I combined CT/TT genotype compared to those with the T399I CC genotype. Our data suggest that TLR4 T399I modify cytokines and chemokines patterns and play a role in the development of NPC. (Cancer Sci 2012; 103: 653–658)Keywords
This publication has 36 references indexed in Scilit:
- The toll‐like receptor 2 (TLR2) ‐196 to ‐174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis CInternational Journal of Cancer, 2011
- TLR2 and TLR4 polymorphisms in familial Mediterranean feverHuman Immunology, 2009
- A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphomaCarcinogenesis, 2008
- Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypesClinical and Experimental Immunology, 2008
- Association of Toll-like receptor–4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesionsHuman Immunology, 2007
- Epstein-Barr Virus Induces MCP-1 Secretion by Human Monocytes via TLR2Journal of Virology, 2007
- A cytokine-mediated link between innate immunity, inflammation, and cancerJournal of Clinical Investigation, 2007
- Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancerBMC Cancer, 2007
- Inflammatory chemokines in cancer growth and progressionEuropean Journal of Cancer, 2006
- Chronic infection, inflammation, andepithelial ovarian cancerMedical Hypotheses, 2001